Johnson & Johnson announced results from additional analyses of the Phase 2 DAHLIAS study highlighting improvement in key measures of disease activity and significant IgG reduction by over 77% ...
Johnson & Johnson’s rebate model aims to address misuse of 340B Program. HRSA’s threats of penalties led J&J to halt the plan ...
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...
Johnson & Johnson MedTech announced that the U.S. Food & Drug Administration has approved the Ottava robotic surgical system ...
Q3 2024 Earnings Call Transcript November 13, 2024 Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS ...
GOP Representative Marjorie Taylor Greene is lashing out at House Speaker Mike Johnson for failing to secure a GOP ...
Bear Development launched a marketing campaign after Johnson Controls moved its downtown operations to Glendale. Bear is ...
ONL Therapeutics Inc. is a classic case of a University of Michigan spinout. The Ann Arbor biotechnology startup netted the largest VC deal in the state in Q3, closing an oversubscribed $65 million ...
Daniel Baker, M.D., will join Cue Biopharma's executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific officer (CSO ...
The Associated Press on MSN10d
House Speaker Johnson Walks Back Talk of Repealing CHIPS ActIn an up for grabs New York congressional district getting a Micron plant through federal grants, a comment that the GOP ...
Dwayne "The Rock" Johnson recently discussed his difficult relationship with his father, WWE Hall of Famer Rocky Johnson, who ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback